You could lose 10% of your body weight or more with these drugs, but you may have to take them for life to keep the weight off.
This could provide another significant treatment option for patients living with diabetes or obesity, Ali says
Moore hopes that the Bridge program will give lower-income people and people of color much better access to GLP-1 medications than in the past
Oral antidiabetic medication was discontinued 3 weeks prior to the study
Over time, this translates into a significant reduction in caloric intake, naturally promoting weight loss
As of 2026, the mots c retatrutide stack remains an area of speculative interest within research communities, with ongoing Phase 3 trials for Retatrutide monotherapy, and MOTS-c primarily available for research purposes, underscoring the need for rigorous scientific investigation into any combined applications